相关实验视频
Updated: Feb 9, 2026

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
22.7K
更多的见解来自 Abca4-/-老鼠模型的衰退Stargardt病
Jin Zhao1, Diego Montenegro1, Sihua Cheng1
1Departments ofOphthalmology.
The Journal of biological chemistry
|February 7, 2026
概括
在Stargardt病 (STGD1) 模型中的光受体退化部分是由光照所驱动的. 减少暴露于光线和饮食中的维生素A可能会保护光受体细胞免受有毒 bisretinoid 积累的影响.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 在ATP结合盒载体ABCA4的突变导致Stargardt病 (STGD1),一个青少年黄斑变性.
- 缺少ABCA4会加速从网膜甲和酸乙醇胺 (PE) 中形成有毒的比斯雷类物质.
研究的目的:
- 为了研究光在ABC4淘汰赛小鼠的光受体退化中的作用.
- 评估饮食和光线对光受体活力和双类固醇积累的影响.
主要方法:
- 比较阿尔比诺与Abouti Abca4淘汰赛小鼠中的光受体细胞活力.
- 黑色养殖的阿尔比诺ABC4淘汰小鼠.
- 分析视网膜蛋白水平,双视网膜蛋白积累和 fundus 自光.
- 使用光谱域光学连贯断层扫描 (SD-OCT) 和光成像.
主要成果:
- 在Abca4淘汰赛小鼠中的光感受器退化至少部分是光驱动的.
- 维生素A含量高和高脂肪饮食降低了光受体的活力.
- 通过自光测量的比斯雷类药物在Abca4淘汰赛小鼠中升高.
- 在SD-OCT上看到的与视网膜结构异常相关的自光点.
结论:
- 在STGD1模型中,暴露于光线会加剧光受体退化.
- 饮食修改和避开光线可能为STGD1.1提供治疗潜力.
- 缺少Abca4会导致比斯雷类积累和特征性视网膜病变.
相关概念视频
Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K
Molecular Models
43.8K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.8K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968

